Mouse M-CSF Recombinant Protein, PeproTech

The University of Virginia awarded contract A207_PO-0474029 to Life Technologies Corporation on August 27, 2026, with a cumulative contract value of $219. Life Technologies Corporation serves as the prime contractor for this procurement, which was established within the Commonwealth of Virginia. While the specific products and services to be delivered under this purchase order are not detailed in the available documentation, Life Technologies Corporation's core business operations typically encompass life sciences equipment, reagents, and related laboratory technologies.

The contract represents a purchase order transaction within the University of Virginia's procurement activity. Specific details regarding the contract's period of performance, place of performance location within Virginia, and the precise scope of deliverables are not provided in the award documentation. The nominal cumulative value of $219 suggests this may represent a small-dollar purchase order, a partial contract notice, or an initial task order under a larger framework agreement. Additional contract documentation would be necessary to clarify the complete scope of products or services being procured under this award.